Richard G. Vincent, Chief Financial Officer at Oncternal Therapeutics, Inc. (ONCT), bought 5,000 shares at $1.45 ($7K) on 2022-03-24, disclosed to the SEC on 2022-03-28.
Open-market purchase of $7k ONCT by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.45 | 3 | $4 | 0.1% |
| 2 | $1.45 | 356 | $516 | 7.2% |
| 3 | $1.48 | 5 | $7 | 0.1% |
| 4 | $1.49 | 2,136 | $3K | 44.1% |
| 5 | $1.40 | 2,500 | $4K | 48.5% |
| Total | $1.44 avg | 5,000 |
| $7K |
| 100% |
| Filing → |